In the present study, the serum metabolite classifier including benzoic acid, creatine, and citrulline was shown to effectively distinguish between T2DM and T2DM(+) HCC individuals, and it was capable of detecting small, early-stage, and AFP(−) T2DM(+) HCC with high sensitivity and specificity. This evidence concerns the gene AFP and hepatocellular carcinoma.